OQROGet OQRO Pro
Insider trade

Zymeworks (ZYME)Director bought ~$1.44M

EcoR1 Capital, Director at Zymeworks, bought ~$1.44M of Zymeworks shares.

~$1.44M
Approx. value · 114K sh @ $12.65
17M
Holds after · shares reported
Traded
Mar 18, 2025
Filed
Mar 19, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jan 16, 2025InsiderDirector purchased ~$1.69M of ZYME shares in the open market
  2. Jan 17, 2025InsiderDirector purchased ~$274K of ZYME shares in the open market
  3. Mar 11, 2025InsiderDirector purchased ~$3.69M of ZYME shares in the open market
  4. Mar 12, 2025InsiderDirector purchased ~$3.59M of ZYME shares in the open market
  5. Mar 13, 2025InsiderDirector purchased ~$5.85M of ZYME shares in the open market
  6. Mar 17, 2025InsiderDirector purchased ~$688K of ZYME shares in the open market
  7. Mar 18, 2025 · this disclosureInsiderDirector purchased ~$1.44M of ZYME shares in the open market

What came next

  1. Mar 19, 2025InsiderDirector purchased ~$737K of ZYME shares in the open market
  2. Mar 20, 2025InsiderDirector purchased ~$950K of ZYME shares in the open market
  3. Mar 21, 2025InsiderDirector purchased ~$397K of ZYME shares in the open market
  4. Mar 24, 2025InsiderDirector purchased ~$297K of ZYME shares in the open market
  5. Mar 25, 2025InsiderDirector purchased ~$690K of ZYME shares in the open market
  6. Mar 26, 2025InsiderDirector purchased ~$537K of ZYME shares in the open market
  7. Mar 31, 2025InsiderDirector purchased ~$52K of ZYME shares in the open market
  8. Apr 1, 2025InsiderDirector purchased ~$565K of ZYME shares in the open market
  9. Apr 2, 2025InsiderDirector purchased ~$881K of ZYME shares in the open market
  10. Apr 3, 2025InsiderDirector purchased ~$1.43M of ZYME shares in the open market
  11. Apr 4, 2025InsiderDirector purchased ~$2.19M of ZYME shares in the open market
  12. Apr 16, 2025InsiderDirector purchased ~$826K of ZYME shares in the open market
  13. Apr 17, 2025InsiderDirector purchased ~$631K of ZYME shares in the open market
  14. May 15, 2025InsiderDirector purchased ~$566K of ZYME shares in the open market
  15. May 19, 2025InsiderDirector purchased ~$70K of ZYME shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Zymeworks

For Zymeworks, OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ZYME page.

Other recent filings by EcoR1 Capital, LLC, Director

The full history of EcoR1 Capital, LLC, Director is on the profile page.

How this filing works

Other disclosures at Zymeworks

Everything OQRO holds on this company is on its ZYME page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data